KCNJ14 and cancer: The results demonstrated that KCNJ14 was downregulated with cancer progression in BRCA; however, KCNJ14 showed higher expression in correlation with the pathological stages of COAD, LIHC, LUAD, ESAD, and STAD (Table S1).